Breaking News
FONT-SIZE Plus   Neg
Share SHARE

Reports: Samsung Plans To Double Smartphone Sales This Year

South Korea's Samsung Electronics Co. Ltd. (SSNLF.PK, SSNNF.PK) plans to sell 380 million mobile handsets and double its sales of smartphones this year, reports said quoting J.K. Shin, president of Samsung's mobile communications division.

Shin was speaking to reporters before the Mobile World Congress trade show in Barcelona, which will be on from February 27 to March 1. The company is expected to introduce several new products at the show, including the new 10.1-inch Galaxy Note and the Galaxy Beam, a projector smartphone.

Samsung said last month that its fourth-quarter profit was boosted by strong sales of its Galaxy smartphones, more than offsetting weakness in flat panels and computer chips. The company's smartphone business also reportedly surpassed major rivals, including Apple Inc. (AAPL), in shipments.

The company sold about 97 million units of smartphones and 327.4 million handsets last year.

The stock is currently down about 0.6 percent on the Kospi at 1,173,000 Korean won.

Click here to receive FREE breaking news email alerts for Samsung Electronics Co. Ltd. and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Editors Pick
Proctor and Gamble (PG) has sold two of its soap brands to European consumer products giant Unilever (UN). Cincinnati-based P&G says the sale includes the global Camay brand, the Zest brand outside of North America and its Talisman manufacturing plant in Mexico. The plant employs approximately... Dish Network is no longer carrying Fox News in yet another dispute for the television provider. Fox News, which changed the face of cable news with its ardent advocacy of conservative issues, went dark Sunday, replaced on Dish by The Blaze, Glen Beck's new right-leaning channel. Fox Business channel... Swiss drug maker Roche Holding said a late-stage trial of its breast cancer drug Kadcyla did not provide superior results compared with an existing therapy.
comments powered by Disqus
FREE Newsletters, Analysis & Alerts

 

Stay informed with our FREE daily Newsletters and real-time breaking News Alerts. Sign up to receive the latest information on business news, health, technology, biotech, market analysis, currency trading and more.